English
Specials
Upgrade
Moneycontrol Be a PRO
Moneycontrol PRO
you are here:
Success
Alert
Please select a Day.
Info
Open Trading Account

Ranbaxy Laboratories Ltd.

Sector: Pharmaceuticals
Add to
Stock not traded in NSE.
Stock not traded in BSE.
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
Note :Financial Information is based on consolidated numbers.
Powered by Powered by Trendlyne
MC Essentials
50% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Stock not eligible for rating

Financials
    Ownerships
      Industry Comparison
        Others
          Powered by Powered by Trendlyne
          Open814.70
          Previous Close859.80
          Volume5,415,702.00
          Value (Lacs)46,564.21
          i  VWAP 847.00
          Beta0.000.00
          High869.70
          Low809.45
          UC Limit36.75
          LC Limit33.25
          52 Week High869.70
          52 Week Low371.50
          TTM EPS-19.07
          TTM PE--
          Sector PE31.17
          Book Value Per Share77.61
          P/B11.08
          Face Value5.00
          Mkt Cap (Rs. Cr.)36,599
          Dividend Yield0.00
          20D Avg Volume0
          20D Avg Delivery(%)--

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          MC Insights

          Stock not eligible for rating

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison

          Shareholding Pattern
          Powered by Powered by Trendlyne

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Historical Prices
          Volume Analysis

          Forum

          Community Sentiments

          Data not Available

          What's your call on today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          16 Sep, 2013

          PACE STOCK BROKING SERVICES PRIVATE LIMITED

          Qty 2123826 Price 333.62 % Traded 0.00
          16 Sep, 2013

          PACE STOCK BROKING SERVICES PRIVATE LIMITED

          Qty 2014675 Price 333.92 % Traded 0.00

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Powered by Powered by Trendlyne

          Insider Transaction Summary

          No Data For Insider Transaction Summary.

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          No Data For Substantial Acquisition of Shares & Takeovers.

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Corporate Action

          • No Data For Announcement.
          + See More
          Date Agenda
          + See More
          Ex-Date Type Dividend (Rs)
          + See More
          Announcement Date Ex-Bonus Ratio
          + See More
          Ex-Split Old FV New FV
          + See More
          Ex-Right Ratio Premium
          + See More
          Date Agenda
          + See More

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary

          No Data For Summary.

          Trend
          Insights

          No Data For Institutional Holder Analysis.

          • No Data For Insight.

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Ranbaxy Labs 859.90 - 36,602.80 - 33.34 0.00 - -879 6,864 5.46
          Gensol Engineer 314.90 -0.25 344.41 - 9.91 8.97 457.54 3 60 0.06
          Galactico Corp 161.10 4.99 184.66 - 12.63 10.35 455.52 1 3 0.12
          Suyog Gurbaxani 45.50 - 113.12 - 9.78 -113.52 - -7 4 10.26
          Assam 442.15 - 63.66 52.83 1.06 2.47 49.10 1 4 0.00
          + See More

          About the Company

          Ranbaxy Laboratories Ltd. is pharmaceutical company. It develops, manufactures and markets generic, branded generic, over-the-counter products, anti-retrovirals, active pharmaceutical ingredients and intermediates. Its products include simvastatin, amoxyclav potassium, isotretinion, ciprofloxacin, isotretinon, cephalexin, ketorolac tromethamine, cefaclor, clarithromycin and cefuroxime axetil. The company was founded in 1961 and is based in Gurgaon, Haryana. Ranbaxy Laboratories Ltd. operates as a subsidiary of Daiichi Sankyo Company Ltd.
          {"success":1,"data":{"address":{"address1":"A-41, Industrial Area,","address2":"Phase-VIII-A,,Sahibzada Ajit Singh Nagar","city":"Mohali","state":"Punjab","pincode":"160071","telephone1":"0172-6678666","telephone2":"","fax1":"0172-5013376","fax2":"","email":"secretarial@ranbaxy.com","web":"http:\/\/www.ranbaxy.com"},"management":[{"name":"Tsutomu Une","designation":"Chairman"},{"name":"Arun Sawhney","designation":"Managing Director & CEO"},{"name":"Akihiro Watanabe","designation":"Director"},{"name":"Anthony H Wild","designation":"Director"},{"name":"Kazunori Hirokawa","designation":"Director"}],"registrars":{"name":"Alankit Assignment Ltd.","address1":"2E\/8, Blazeflash House,","address2":"R T A Division, 1st Floor","address3":"Jhandewalan Extension,","address4":"","telephone":"011-51540060, 51540061, 51540062, 51540063","fax":"011-51540064","email":"nahar@alankit.com","internet":"","city":"New Delhi","state":"Delhi","pincode":"110055"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"}],"details":{"bseId":"500359","nseId":"RANBAXY","series":"","isinid":"INE015A01028"}}}

          • Registered Office

          • Registrars

            • Address

              2E/8, Blazeflash House,,R T A Division, 1st Floor

            • City

              New Delhi 110055

            • State

              Delhi

            • Tel. No.

              011-51540060, 51540061, 51540062, 51540063

            • Fax No.

              011-51540064

            • Email

              nahar@alankit.com

            • Internet

          • Management

            • Tsutomu Une

              Chairman

            • Arun Sawhney

              Managing Director & CEO

            • Akihiro Watanabe

              Director

            • Anthony H Wild

              Director

            • Kazunori Hirokawa

              Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

          • Details

            • BSE:

              500359

            • NSE:

              RANBAXY

            • Series

            • ISIN

              INE015A01028

          Go to Top

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>

          Sections
          Desktop Version »
          Follow us on
          Facebook Twitter Instagram Teglegram Jio News
          Available On
          Download from Google Play Download from App Stoer Download from Windows Phone
          ISO 27001 - BSI Assurance Mark
          Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Contact Us | Advertise with Us
          Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

          Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.